FindTrial
Sign In

TO CHECK THE PAIN RELIVING ACTION OF ROPIVACAINE VERSUS LEVOBUPIVACAINE IN PATIENT UNDERGOING BREAST SURGERY.

COMPARATIVE EVALUATION OF POST OPERATIVE ANALGESIC EFFECTS OF WOUND INFILTRATION WITH ROPIVACAINE VERSUS LEVOBUPIVACAINE IN MODIFIED RADICAL MASTECTOMY.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016311
Enrollment
60
Registered
2018-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: ROPIVACAINE: 0.75% ACCORDING TO BODY WEIGHT WOUND INFILTRATION SINGLE DOSE AT END OF SURGERY OBSERVED UPTO 24HOURS Control Intervention1: LEVOBUPIVACAINE: 0.5% ACCORDING TO BODY WEIGHT

Sponsors

Department of Anesthesiology kidwai Cancer Institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 and 2 Consenting patient Weight 50-70kg

Exclusion criteria

Exclusion criteria: Patient refusal History of allergy Severe renal liver cardiac and pulmonary dysfunction Unable to comprehend VAS scale

Design outcomes

Primary

MeasureTime frame
Analgesic efficacy VAS scaleTimepoint: Post operatively 0min, 15min, 30min, 45min, 60min,90min,2,4,8,12,16,20 and 24hours.—

Secondary

MeasureTime frame
Requirements of rescue analgesia Incidence and severity of side effectTimepoint: Post operative period in first 24hrs—

Countries

India

Contacts

Public ContactJEAN HANNAH PHILIP

Kidwai Cancer Institute

vbchethana@yahoo.com9845259264

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026